Primary care naloxone and opioid co-prescribing reduces emergency visits Study shows that co-prescribing naloxone in primary care to patients taking opioids for pain reduces emergency department visits by 47% within six months.…
Patients nearing death subject to unnecessary treatments and procedures More than a third of older patients who are facing the end of their lives in acute hospitals are given unnecessary drugs, according to new research.…
Nurofen TV advertisement banned by advertising watchdog The advertising watchdog has banned a TV advertisement for one of the UK’s biggest painkiller brands, Nurofen, because it falsely claims that the product could specifically target joint and back pain.…
FDA issues warning over loperamide heart risksThe US Food and Drug Administration (FDA) has issued a warning that high doses of the anti-diarrheal medication loperamide are associated with a risk of heart problems.…
Teva’s biological drug improves chronic migraine symptoms A monoclonal antibody developed for chronic migraine can improve patients’ symptoms within a few days, results of a study carried out by the drug’s manufacturer Teva Pharmaceuticals show.…
Morphine prolongs neuropathic pain in rats Administration of morphine following nerve injury can prolong the duration of pain, even after treatment has stopped, a study in rats has found.…
Paracetamol makes it harder for brain to detect errors Over-the-counter painkiller paracetamol may be making it more difficult for the brain to detect errors, according to research.…
Meet the regional finalists of I Love My Pharmacist: London and Kent The public has until 21 July 2016 to vote for their favourite regional finalist of the 2016 I Love My Pharmacist Award. The pharmacist with the highest number of votes in each region will then meet with the judging panel who will decide the 2016 champion.…
Making the case for drug consumption rooms For the past 15 years, drug users living in Sydney, Australia, have had access to a safe place to inject their drugs, supervised by trained medical staff. Is it time for other cities to follow suit?…
Study questions perceived stroke risk of some migraine drugs Triptans and dihydroergotamine can be used to treat basilar and hemiplegic migraine without an increased risk of stroke, according to research published in the May 2016 issue of Headache.…